Y Nakamura, H Yanagawa, H Kato, K Harada, T Kawasaki
{"title":"Mortality among patients with a history of Kawasaki disease: the third look. The Kawasaki Disease Follow-up Group.","authors":"Y Nakamura, H Yanagawa, H Kato, K Harada, T Kawasaki","doi":"10.1111/j.1442-200x.1998.tb01960.x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Long-term prognosis of Kawasaki disease is still unclear.</p><p><strong>Methods: </strong>In a cohort study, 6576 patients with Kawasaki disease were observed from their first medical encounter because of the disease through the end of 1994, or until death. Standardized mortality ratios (SMR) with 95% confidence intervals (CI) were calculated with vital statistics data of Japan used for the control.</p><p><strong>Results: </strong>Of 6576 patients who met the eligibility criteria, 6550 (99.6%) were followed through either the end of the study or the date of death. Twenty patients (14 male, 6 female subjects) died during the study period; an overall SMR of 1.35 (95% CI 0.82-2.08) was calculated. The SMR was 1.45 (95% CI 0.79-2.44) for male subjects and 1.15 (95% CI 0.42-2.52) for female subjects. During the acute phase of the disease (the first 2 months after the first visit to hospital), the SMR was higher, particularly in male subjects (SMR 10.13, 95% CI 3.72-22.08). After the acute phase, however, both boys and girls had low SMR. Nine of the 20 deaths were caused by Kawasaki disease; there were three deaths as a result of congenital heart diseases and two subjects died of malignant neoplasms of lymphatic or hematopoietic tissues.</p><p><strong>Conclusions: </strong>Although the mortality rate among those with a history of Kawasaki disease was elevated in Japan, many of the deaths that caused the elevation occurred during the acute phase of the disease. The mortality rate was not increased after the acute phase of the disease.</p>","PeriodicalId":76975,"journal":{"name":"Acta paediatrica Japonica : Overseas edition","volume":"40 5","pages":"419-23"},"PeriodicalIF":0.0000,"publicationDate":"1998-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1442-200x.1998.tb01960.x","citationCount":"34","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta paediatrica Japonica : Overseas edition","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/j.1442-200x.1998.tb01960.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 34
Abstract
Background: Long-term prognosis of Kawasaki disease is still unclear.
Methods: In a cohort study, 6576 patients with Kawasaki disease were observed from their first medical encounter because of the disease through the end of 1994, or until death. Standardized mortality ratios (SMR) with 95% confidence intervals (CI) were calculated with vital statistics data of Japan used for the control.
Results: Of 6576 patients who met the eligibility criteria, 6550 (99.6%) were followed through either the end of the study or the date of death. Twenty patients (14 male, 6 female subjects) died during the study period; an overall SMR of 1.35 (95% CI 0.82-2.08) was calculated. The SMR was 1.45 (95% CI 0.79-2.44) for male subjects and 1.15 (95% CI 0.42-2.52) for female subjects. During the acute phase of the disease (the first 2 months after the first visit to hospital), the SMR was higher, particularly in male subjects (SMR 10.13, 95% CI 3.72-22.08). After the acute phase, however, both boys and girls had low SMR. Nine of the 20 deaths were caused by Kawasaki disease; there were three deaths as a result of congenital heart diseases and two subjects died of malignant neoplasms of lymphatic or hematopoietic tissues.
Conclusions: Although the mortality rate among those with a history of Kawasaki disease was elevated in Japan, many of the deaths that caused the elevation occurred during the acute phase of the disease. The mortality rate was not increased after the acute phase of the disease.
背景:川崎病的长期预后尚不清楚。方法:在一项队列研究中,6576例川崎病患者从首次就诊到1994年底,或直到死亡。采用日本生命统计资料作为对照,计算标准化死亡率(SMR)和95%可信区间(CI)。结果:在符合资格标准的6576例患者中,6550例(99.6%)被随访至研究结束或死亡日期。20例患者(男性14例,女性6例)在研究期间死亡;总体SMR为1.35 (95% CI 0.82-2.08)。男性受试者的SMR为1.45 (95% CI 0.79-2.44),女性受试者的SMR为1.15 (95% CI 0.42-2.52)。在疾病的急性期(首次就诊后的前2个月),SMR较高,尤其是男性受试者(SMR为10.13,95% CI 3.72-22.08)。然而,在急性期后,男孩和女孩的SMR都很低。20例死亡中有9例是由川崎病引起的;有3人死于先天性心脏病,2人死于淋巴或造血组织的恶性肿瘤。结论:尽管日本有川崎病病史者的死亡率升高,但导致死亡率升高的许多死亡发生在该病的急性期。急性期后死亡率没有增加。